Lung Cancer Trial, Recruiting NCT06476249 Sponsor: Hematology department of the 920th hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06476249
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 70 years of age and have had a type of lung removal surgery performed using a minimally invasive camera-assisted technique (called video-assisted thoracoscopic pneumonectomy).

Who may not be able to join:

  • People who had a cough before their surgery, for example due to asthma or from taking a type of blood pressure medication called ACE inhibitors.
  • People whose cancer has spread to distant parts of the body.
  • People who are currently pregnant or breastfeeding.
  • People who have other serious ongoing health conditions, such as another cancer, chronic liver disease, or chronic kidney disease.
  • People who have a diagnosed mental illness.
  • People who are unwilling to attend follow-up appointments or whose medical records are incomplete.
  • People whose ability to follow the trial's requirements is considered poor, or who the trial investigators decide are not suitable for other reasons (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wenk Cai, doctor, the Vice-President of the 920th Hospital of the Joint Logistics Support Force

Phone: +8613808743327

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hematology department of the 920th hospital
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
1 March 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The score value of Mandarin Chinese version of the Leicester Cough Questionnaire; The score value of visual analogue scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov